Sources and Effects of Angiotensin Peptides in Atherosclerosis

Grants and Contracts Details


This is a revised application, for which we have now developed the mice that were requested in the previous reviews: floxed angiotensinogen and AT1a receptors. Therefore, all the critical reagents to the proposed studies are now available. Evidence has evolved, primarily in the last decade, demonstrating that the renin angiotensin system (RAS) has a profound effect on atherogenic mechanisms. However, many questions remain regarding the origin of the bioactive peptides and the mechanisms of the effects. Based on the findings of the previously funded period and others, the focus of the proposed research is to determine the relative importance of the systemic versus local RAS to the development of atherosclerosis. The central hypothesis of this proposal is that macrophage-derived RAS components are responsible for the local generation of angiotensin peptides that propagate atherosclerosis primarily via stimulation of ATIa receptors expressed on endothelial cells. To determine the validity of this hypothesis, the following specific aims are proposed: Aim 1. Determine the contribution of angiotensinogen from the liver (systemic) versus macrophages (local) to lesion size and characteristics of hypercholesterolemia-induced atherosclerosis. Aim 2. Determine the contribution of ACEI and ACE2 expression on bone marrow-derived cells to the development of atherosclerotic lesion size and characteristica Aim 3. Determine the cellular location of A Tia receptor expression that influences the atherogenic process.
Effective start/end date9/20/0011/30/13


  • National Heart Lung and Blood Institute: $1,461,338.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.